�������ýҕ�l

The White House announced Thursday a $140 million, 22-target research agenda for monkeypox to better understand and handle rising case counts across the country. The agenda aims to improve data on transmission, testing, vaccines, equitable treatments and environmental factors. (Payne, 7/21)

Rep. Carolyn Maloney (D-N.Y.), chair of the House Oversight and Reform Committee, on Wednesday asked the Department of Health and Human Services (HHS) to address the “barriers” to monkeypox treatment that people have reported dealing with so far. (Choi, 7/21)

Monkeypox patients around the world are suffering from symptoms not normally linked to the virus, leading to missed and mistaken diagnoses, researchers said. (Muller, 7/21)

The spread of monkeypox in the U.S. could represent the dawn of a new sexually transmitted disease, though some health officials say the virus that causes pimple-like bumps might yet be contained before it gets firmly established. Experts don’t agree on the likely path of the disease, with some fearing that it is becoming so widespread that it is on the verge of becoming an entrenched STD — like gonorrhea, herpes and HIV. (Stobbe, 7/22)

Vaccines for the monkeypox virus should be prioritized for men who have sex with men, according to experts. (Thomson, 7/21)

During opening remarks, WHO Director-General Tedros Adhanom Ghebreyesus, PhD, said worldwide cases are mostly still in men who have sex with men (MSM). (Soucheray, 7/21)